Natural Killer Cell (CYNK-001) Infusions in Adults with AML

NCT04310592 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Neoplasms by Histologic Type
Neoplasms
Immunosuppressive Agents
Immunologic Factors
Physiological Effects of Drugs
Alkylating Agents
Antimetabolites, Antineoplastic
Antiviral Agents
Analgesics, Non-narcotic
Anti-infective Agents
Analgesics
Peripheral Nervous System Agents
Hematologic Diseases
Hematologic Neoplasms
Leukemia in Remission
Relapsed Adult AML
Refractory AML

Interventions

BIOLOGICAL: CYNK-001

Sponsor

Celularity Incorporated